soul trial oral semaglutide cardiovascular outcomes trial SELECT Oral Semaglutide's Impact on Cardiovascular

Monitor renal function Assess hydration status regularly Evaluate for gastrointestinal intolerance 14.2 Administration to Pregnant Women and Nursing Mothers 14.2.1 Risk-Benefit Assessment in Pregnancy Semaglutide is generally not recommended during pregnancy

Patent expiry in March 2026 invites further generics, potentially accelerating volume but pressuring branded margins within the Latin America GLP-1 agonists market

Safety, standardization, and regulatory considerations For targeted strategies, risk is low when products meet strain-level identity, potency-at-expiry, and contaminant specifications under GMP-aligned manufacturing

Song X, Jia H, Jiang Y, Wang L, Zhang Y, Mu Y, et al

Working with a healthcare provider for regular monitoring and personalized care is the best way to ensure their continued effectiveness and safety